Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$19 2544
2025
Q4
$19 Buy
+1
New +$17 ﹤0.01% 2525
2025
Q2
Sell
-466
Closed -$8.27K 2469
2025
Q1
$8.27K Hold
466
﹤0.01% 1976
2024
Q4
$9.98K Buy
466
+436
+1,453% +$10.6K ﹤0.01% 1869
2024
Q3
$466 Buy
30
+17
+131% +$423 ﹤0.01% 2801
2024
Q2
$138 Buy
+13
New +$157 ﹤0.01% 2673
2024
Q1
Sell
-52
Closed 2260
2023
Q4
$0 Buy
+52
New +$426 ﹤0.01% 2508
2023
Q1
Sell
-11
Closed 2334
2022
Q4
$0 Buy
+11
New +$163 ﹤0.01% 2248

Other funds holding CDNA

Blue Trust Inc's CDNA Position: Q1 2026 in Review

Blue Trust Inc sold out of CareDx (CDNA) in Q1 2026, closing a stake of 1 share — an estimated $19 sold.

Blue Trust Inc first reported a position in CDNA in Q4 2022 and held it in 7 quarters. The position peaked at $9.98K in Q4 2024. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Blue Trust Inc reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
  • Blue Trust Inc sold 1 CareDx share in Q1 2026, an estimated $19.
  • Blue Trust Inc first reported a position in CareDx in Q4 2022 and held it in 7 quarters.
  • Blue Trust Inc's CareDx position peaked at $9.98K in Q4 2024.
  • 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.